Companies
Wondfo Biotech
scaling highly affordable POCT solutions for both domestic rural healthcare and massive export markets.
- Country
- China
- Ticker
- 300482.SZ
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | RMB 2.087 billion (2025 revenue) | en.wondfo.com |
| Capacity | 1.5 million test kits daily; 200 million test kits annually medium confidence | chinaservicesinfo.com |
| Certification | ISO 13485, CE, FDA, MDSAP, CNAS laboratory accreditation | static.cninfo.com.cn |
| Regulatory approval | NMPA, FDA EUA, CE, MDALL registrations | static.cninfo.com.cn · en.wondfo.com |
| Production site | Guangzhou Science City, China; international factories in Asia, South America, and Africa (planned/established) | en.wondfo.com · chinaservicesinfo.com · fanamc.com |
| Headcount | 3000+ employees | en.wondfo.com · fanamc.com |
| Revenue | RMB 2.087 billion (2025 annual revenue) | en.wondfo.com |
Independent sources: chinaservicesinfo.com · en.wondfo.com · fanamc.com · static.cninfo.com.cn
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Diagnostics & biosensors | diagnostics-medtech | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.